tirzepatide approval date FDA approves Lilly's Mounjaro™ (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2 diabetes Zepbound (tirzepatide) FDA Approval History
Pay in 4 interest-free payments of $5.68 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30




00459-9/asset/8e7c3870-3c4b-49d0-829c-9a335754f0ab/main.assets/gr2.jpg)





















